tradingkey.logo

Bio-Techne Corp

TECH
查看詳細走勢圖
57.971USD
-0.539-0.92%
交易中 美東報價延遲15分鐘
9.03B總市值
116.08本益比TTM

Bio-Techne Corp

57.971
-0.539-0.92%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-0.92%

5天

-6.01%

1月

-2.37%

6月

+14.75%

今年開始到現在

-19.52%

1年

-23.41%

查看詳細走勢圖

TradingKey Bio-Techne Corp股票評分

單位: USD 更新時間: 2025-12-12

操作建議

Bio-Techne Corp當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在生物技術與醫療研究行業排名49/404位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價69.40。中期看,股價處於上升通道。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Bio-Techne Corp評分

相關信息

行業排名
49 / 404
全市場排名
144 / 4592
所屬行業
生物技術與醫療研究

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 17 分析師
買入
評級
69.402
目標均價
+15.11%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Bio-Techne Corp亮點

亮點風險
Bio-Techne Corporation develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, advanced tissue-based in-situ hybridization assays and instrumentation for spatial genomic and tissue biopsy analysis and genetic and oncology kits for research and clinical applications. Its product portfolio and application enable scientific investigations into biological processes and molecular diagnostics and progression of specific diseases.
高分紅
公司屬於高分紅公司,最新股息支付率68.69%
穩定分紅
公司5年內持續分紅,最新股息支付率68.69%
估值高估
公司最新PE估值117.16,處於3年歷史高位
機構減倉
最新機構持股161.18M股,環比減少4.35%
ETHSX持倉
明星投資者ETHSX持倉,最新持倉93.35K股

Bio-Techne Corp新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Bio-Techne Corp簡介

Bio-Techne Corporation develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, advanced tissue-based in-situ hybridization assays and instrumentation for spatial genomic and tissue biopsy analysis and genetic and oncology kits for research and clinical applications. Its product portfolio and application enable scientific investigations into biological processes and molecular diagnostics and progression of specific diseases.
公司代碼TECH
公司Bio-Techne Corp
CEOKelderman (Kim)
網址https://www.bio-techne.com/

常見問題

Bio-Techne Corp(TECH)的當前股價是多少?

Bio-Techne Corp(TECH)的當前股價是 57.971。

Bio-Techne Corp 的股票代碼是什麼?

Bio-Techne Corp的股票代碼是TECH。

Bio-Techne Corp股票的52週最高點是多少?

Bio-Techne Corp股票的52週最高點是79.280。

Bio-Techne Corp股票的52週最低點是多少?

Bio-Techne Corp股票的52週最低點是46.010。

Bio-Techne Corp的市值是多少?

Bio-Techne Corp的市值是9.03B。

Bio-Techne Corp的淨利潤是多少?

Bio-Techne Corp的淨利潤為73.36M。

現在Bio-Techne Corp(TECH)的股票是買入、持有還是賣出?

根據分析師評級,Bio-Techne Corp(TECH)的總體評級為買入,目標價格為69.402。

Bio-Techne Corp(TECH)股票的每股收益(EPS TTM)是多少

Bio-Techne Corp(TECH)股票的每股收益(EPS TTM)是0.499。
KeyAI